Company intelligence / Profile preview

Shenyang Sansheng Pharmaceutical Co., Ltd.

Shenyang, Liaoning, China3sbio.com ↗
Ownership
Private
Employees
~5412
Development stage
Preclinical
01

Overview

The company has multiple approved products in China and internationally, including Recombinant Human Thrombopoietin (rhTPO) approved in China in 2005 for chemotherapy-induced thrombocytopenia and in 2010 for immune thrombocytopenia. Their etanercept product has shown strong sales growth with approval for 3 indications and a new pre-filled water injection type approved in March 2023.

Therapeutic areas
OncologyImmunologyHematologyDermatologyRheumatologyOphthalmologyNephrologyInfectious Diseases
Modalities
Monoclonal antibodiesBispecific antibodiesSmall moleculesBiological productsBiosimilarsColony-stimulating factorsTraditional Chinese Medicine
Industry
Biotech
02

Drug pipeline

1 asset

recombinant human thrombopoietin

4
03

Partnerships

AstraZeneca (exclusive license agreement for Byetta and Bydureon in China)

Beyond the preview

Go deeper on Shenyang Sansheng Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenyang Sansheng Pharmaceutical Co., Ltd..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call